Emerging cytokine networks in colorectal cancer

NR West, S McCuaig, F Franchini… - Nature Reviews …, 2015 - nature.com
Cytokine networks are crucial aspects of tumour immunology, particularly for colorectal
cancer (CRC), in which inflammation and antitumour immunity are key determinants of …

[HTML][HTML] Do STAT3 inhibitors have potential in the future for cancer therapy?

ALA Wong, JL Hirpara, S Pervaiz, JQ Eu… - Expert opinion on …, 2017 - Taylor & Francis
Signal transduction activator of transcription (STAT) 3 is a member of the STAT protein family
which transduces intracellular and extracellular signals to the nucleus, controlling the …

[HTML][HTML] Cytokines and chemokines as mediators of prostate cancer metastasis

TO Adekoya, RM Richardson - International journal of molecular sciences, 2020 - mdpi.com
The consequences of prostate cancer metastasis remain severe, with huge impact on the
mortality and overall quality of life of affected patients. Despite the convoluted interplay and …

Inhibition of IL‐6‐JAK/Stat3 signaling in castration‐resistant prostate cancer cells enhances the NK cell‐mediated cytotoxicity via alteration of PD‐L1/NKG2D ligand …

LJ Xu, XD Chen, MJ Shen, DR Yang, L Fang… - Molecular …, 2018 - Wiley Online Library
To investigate whether IL‐6 signaling affects the susceptibility of castration‐resistant
prostate cancer (CRPC) cells to cytotoxic action of natural killer (NK) cells, CRPC cell lines …

[HTML][HTML] The role and mechanism of epithelial-to-mesenchymal transition in prostate cancer progression

UG Lo, CF Lee, MS Lee, JT Hsieh - International journal of molecular …, 2017 - mdpi.com
In prostate cancer (PCa), similar to many other cancers, distant organ metastasis symbolizes
the beginning of the end disease, which eventually leads to cancer death. Many …

Interleukin-6 and prostate cancer: Current developments and unsolved questions

Z Culig, M Puhr - Molecular and cellular endocrinology, 2018 - Elsevier
Abstract Interleukin (IL)-6 is a pro-inflammatory cytokine that is expressed in prostate tumors
and in the stromal tumor micro-enviroment. It is known to regulate proliferation, apoptosis …

Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge

V Goffin - Pharmacology & therapeutics, 2017 - Elsevier
In the era of precision medicine, the identification of new targets is a constant challenge to
improve cancer therapy. Preclinical investigations, epidemiological studies and analyses of …

Targeted blockade of JAK/STAT3 signaling inhibits ovarian carcinoma growth

G Gritsina, F Xiao, SW O'Brien, R Gabbasov… - Molecular cancer …, 2015 - AACR
Ovarian carcinoma is the fifth leading cause of death among women in the United States.
Persistent activation of STAT3 is frequently detected in ovarian carcinoma. STAT3 is …

[HTML][HTML] Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges

S Arshad, M Naveed, M Ullia, K Javed, A Butt… - … and Molecular Biology, 2020 - SciELO Brasil
Signal transducers and activators of transcription 3 (STAT-3) is a transcription factor that
regulates the gene expression of several target genes. These factors are activated by the …

[HTML][HTML] Circulating cytokine levels as markers of inflammation in Philadelphia negative myeloproliferative neoplasms: diagnostic and prognostic interest

J Mondet, K Hussein, P Mossuz - Mediators of inflammation, 2015 - hindawi.com
Cytokines are well known mediators of numerous physiological and pathological processes.
They contribute to the regulation of normal hematopoiesis but increasing data suggest that …